文献速递甲状腺与颈部外科

甲状腺髓样癌30年:表现、治疗与生存趋势

Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
PubMed 文献 · Surgery · 2016-11-11

基于SEER登记数据,比较1983-1992、1993-2002和2003-2012三个时期甲状腺髓样癌患者的表现、手术范围和疾病特异性生存趋势。共纳入2940例患者,发病率从0.14/10万升至0.21/10万,诊断平均年龄从49.8岁升至53.8岁,肿瘤≤1cm比例从11.4%升至25.1%,全甲状腺切除加淋巴结清扫比例从58.2%升至76.5%,5年疾病特异性生存从86%改善至89%。

要点

  • 甲状腺髓样癌发病率上升,诊断年龄增大,小肿瘤比例增加但分期不变。
  • 全甲状腺切除加淋巴结清扫比例从58.2%增至76.5%。
  • 5年疾病特异性生存从86%改善至89%,区域和远处病变改善更明显。

核心结论

  • 甲状腺髓样癌手术范围扩大,疾病特异性生存改善,主要体现在区域和远处病变患者。

研究设计与样本

  • 基于SEER登记数据的回顾性趋势分析,比较1983-1992、1993-2002和2003-2012三个时期,共纳入2940例甲状腺髓样癌患者。

主要发现

  • 发病率从0.14/10万升至0.21/10万,诊断平均年龄从49.8岁升至53.8岁(P < .001)。
  • 肿瘤≤1cm比例从11.4%升至25.1%(P < .001),但分期保持不变(P = .57)。
  • 全甲状腺切除加淋巴结清扫比例从58.2%升至76.5%(P < .001)。
  • 5年疾病特异性生存从86%改善至89%(P < .001),区域病变从82%升至91%(P = .003),远处病变从40%升至51%(P = .02)。

临床怎么用

  • 甲状腺髓样癌手术趋于更积极,全甲状腺切除加淋巴结清扫比例增加,生存改善支持该趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of recent medical advances on disease presentation, extent of operation, and disease-specific survival for patients with medullary thyroid cancer is unclear. METHODS: We used the Surveillance, Epidemiology, and End Results registry to compare trends over 3 time periods, 1983-1992, 1993-2002, and 2003-2012. RESULTS: There were 2,940 patients diagnosed with medullary thyroid cancer between 1983 and 2012. The incidence of medullary thyroid cancer increased during this time period from 0.14 to 0.21 per 100,000 population, and mean age at diagnosis increased from 49.8 to 53.8 (P < .001). The proportion of tumors ≤1 cm also increased from 11.4% in 1983-1992, 19.6% in 1993-2002, to 25.1% in 2003-2012 (P < .001), but stage at diagnosis remained constant (P = .57). In addition, the proportion of patients undergoing a total thyroidectomy and lymph node dissection increased from 58.2% to 76.5% during the study period (P < .001). In the most recent time interval, 5-year, disease-specific survival improved from 86% to 89% in all patients (P < .001) but especially for patients with regional (82% to 91%, P = .003) and distant (40% to 51%, P = .02) disease. CONCLUSION: These data demonstrate that the extent of operation is increasing for patients with medullary thyroid cancer. Disease-specific survival is also improving, primarily in patients with regional and distant disease.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Randle RW, Balentine CJ, Leverson GE, et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery. 2016. PMID: 27842913. doi:10.1016/j.surg.2016.04.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。